Multidrug‐resistant organisms in allogeneic hematopoietic cell transplantation

Abstract: Objective multidrug-resistant organisms (MDRO) are a challenge in allogeneic hematopoietic cell transplantation (HCT). However, in the literature there is no comprehensive analysis on MDRO in HCT. In this retrospective, single-center analysis, we appraised prevalence and clinical impact of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Heidenreich, Daniela (VerfasserIn) , Kreil, Sebastian (VerfasserIn) , Nolte, Florian (VerfasserIn) , Hofmann, Wolf-Karsten (VerfasserIn) , Miethke, Thomas (VerfasserIn) , Klein, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 January 2017
In: European journal of haematology
Year: 2017, Jahrgang: 98, Heft: 5, Pages: 485-492
ISSN:1600-0609
DOI:10.1111/ejh.12859
Online-Zugang:Verlag, kostenfrei registrierungspflichtig, Volltext: http://dx.doi.org/10.1111/ejh.12859
Verlag, kostenfrei registrierungspflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/ejh.12859
Volltext
Verfasserangaben:Daniela Heidenreich, Sebastian Kreil, Florian Nolte, Wolf K. Hofmann, Thomas Miethke,Stefan A. Klein
Beschreibung
Zusammenfassung:Abstract: Objective multidrug-resistant organisms (MDRO) are a challenge in allogeneic hematopoietic cell transplantation (HCT). However, in the literature there is no comprehensive analysis on MDRO in HCT. In this retrospective, single-center analysis, we appraised prevalence and clinical impact of MDRO in 98 consecutive allogeneic HCT patients. Method: Prior to the conditioning (baseline) and whenever clinically indicated patients underwent a full screening for MDRO (stool and urine cultures, swabs from several body regions). Results: It turned out that 26 patients were colonized by 33 MDRO, either at baseline (n=16) or at any other time until day 100 post?transplantation. Of these 26 patients, eight developed an infection with MDRO, four of them by 4MRGN Pseudomonas aeruginosa, and three of them died MDRO-related. However, there was no significant difference between MDRO-colonized and non-colonized patients regarding overall survival (OS) and non-relapse-mortality (NRM). There was only a trend toward a higher NRM in patients already colonized by MDRO at baseline. This was due to the high NRM in multidrug-resistant P. aeruginosa-colonized patients. Conclusion: In summary, colonization with MDRO other than P. aeruginosa had no negative impact on NRM and OS. Patients colonized by multidrug-resistant P. aeruginosa had a dismal outcome. HCT of these patients should be considered with care. Screening for MDRO in the pretransplant work-up is suggested.
Beschreibung:Gesehen am 12.04.2018
Beschreibung:Online Resource
ISSN:1600-0609
DOI:10.1111/ejh.12859